Sign in

CIK 0001781983

  • Non-accelerated filer
  • Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-06-30 ROCKLAGE SCOTT M Director Grant or award · Stock Option (right to Buy) +5,600 5,600
2020-06-16 ROCKLAGE SCOTT M Director Sale −115,357 $33.30 $3.8M 1,823,192
2020-06-16 ROCKLAGE SCOTT M Director Sale −4,807 $33.30 $160K 75,965
2020-06-11 ROCKLAGE SCOTT M Director Sale −235,200 $28.75 $6.8M 1,938,549
2020-06-11 ROCKLAGE SCOTT M Director Sale −9,800 $28.75 $282K 80,772
2020-05-19 ROCKLAGE SCOTT M Director Sale −244,800 $35.15 $8.6M 2,173,748
2020-05-19 ROCKLAGE SCOTT M Director Sale −10,200 $35.15 $359K 90,572
2019-10-07 ROCKLAGE SCOTT M Director Conversion +1,913,910 1,926,073
2019-10-07 ROCKLAGE SCOTT M Director Conversion +79,746 80,253
2019-10-07 ROCKLAGE SCOTT M Director Conversion +492,475 2,418,548
2019-10-07 ROCKLAGE SCOTT M Director Conversion +20,519 100,772
2019-10-07 ROCKLAGE SCOTT M Director Conversion · Series B Convertible Preferred Stock −1,913,910 0
2019-10-07 ROCKLAGE SCOTT M Director Conversion · Series B Convertible Preferred Stock −79,746 0
2019-10-07 ROCKLAGE SCOTT M Director Conversion · Series C Convertible Preferred Stock −492,475 0
2019-10-07 ROCKLAGE SCOTT M Director Conversion · Series C Convertible Preferred Stock −20,519 0

Page 1 of 1 · 15 trades